Olwen Hahn to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications Olwen Hahn has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
0.177
-
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
Score: 0.156
-
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. Am J Clin Oncol. 2011 Apr; 34(2):150-4.
Score: 0.021